Building a Novel Dry Powder Delivery Platform and Applications in IPF
Time: 4:00 pm
day: Day One
Details:
- Highlighting the already established success of MannKind’s proprietary dry powder delivery platform
- Presenting a status update on the Phase 1 study of Nintedanib DPI
- Exploring what’s next for Nintedanib DPI
